Advances in alternative pharmacotherapy of ADHD.
Article
em En
| IMSEAR
| ID: sea-39859
ABSTRACT
Several alternatives to psychostimulants have been developed and expanded the variability of the treatment of ADHD. Clonidine is a good option for managing core behavioral symptoms, especially hyperactivity and impulsivity. Bupropion and venlafaxine seem potentially promising. Significant new options include norepinephrine reuptake inhibitors, such as atomoxetine, and possibly selective dopamine agonists. Central anticholinesterases, such as donepezil, may improve core ADHD symptoms.
Texto completo:
1
Índice:
IMSEAR
Assunto principal:
Piperidinas
/
Transtorno do Deficit de Atenção com Hiperatividade
/
Humanos
/
Resultado do Tratamento
/
Bupropiona
/
Clonidina
/
Agonistas alfa-Adrenérgicos
/
Indanos
/
Antidepressivos Tricíclicos
Idioma:
En
Ano de publicação:
2005
Tipo de documento:
Article